Literature DB >> 29116505

Construction of High-Quality Camel Immune Antibody Libraries.

Ema Romão1, Vianney Poignavent2, Cécile Vincke1, Christophe Ritzenthaler2, Serge Muyldermans3, Baptiste Monsion2.   

Abstract

Single-domain antibodies libraries of heavy-chain only immunoglobulins from camelids or shark are enriched for high-affinity antigen-specific binders by a short in vivo immunization. Thus, potent binders are readily retrieved from relatively small-sized libraries of 107-108 individual transformants, mostly after phage display and panning on a purified target. However, the remaining drawback of this strategy arises from the need to generate a dedicated library, for nearly every envisaged target. Therefore, all the procedures that shorten and facilitate the construction of an immune library of best possible quality are definitely a step forward. In this chapter, we provide the protocol to generate a high-quality immune VHH library using the Golden Gate Cloning strategy employing an adapted phage display vector where a lethal ccdB gene has to be substituted by the VHH gene. With this procedure, the construction of the library can be shortened to less than a week starting from bleeding the animal. Our libraries exceed 108 individual transformants and close to 100% of the clones harbor a phage display vector having an insert with the length of a VHH gene. These libraries are also more economic to make than previous standard approaches using classical restriction enzymes and ligations. The quality of the Nanobodies that are retrieved from immune libraries obtained by Golden Gate Cloning is identical to those from immune libraries made according to the classical procedure.

Entities:  

Keywords:  Golden gate cloning; Immune libraries; Nanobodies; Single-domain antibodies; VHH

Mesh:

Substances:

Year:  2018        PMID: 29116505     DOI: 10.1007/978-1-4939-7447-4_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Identification of Nanobodies Blocking Intimate Adherence of Shiga Toxin-Producing Escherichia coli to Epithelial Cells.

Authors:  David Ruano-Gallego; Luis Ángel Fernández
Journal:  Methods Mol Biol       Date:  2021

2.  Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.

Authors:  Guillermo Valenzuela Nieto; Ronald Jara; Daniel Watterson; Naphak Modhiran; Alberto A Amarilla; Johanna Himelreichs; Alexander A Khromykh; Constanza Salinas-Rebolledo; Teresa Pinto; Yorka Cheuquemilla; Yago Margolles; Natalia López González Del Rey; Zaray Miranda-Chacon; Alexei Cuevas; Anne Berking; Camila Deride; Sebastián González-Moraga; Héctor Mancilla; Daniel Maturana; Andreas Langer; Juan Pablo Toledo; Ananda Müller; Benjamín Uberti; Paola Krall; Pamela Ehrenfeld; Javier Blesa; Pedro Chana-Cuevas; German Rehren; David Schwefel; Luis Ángel Fernandez; Alejandro Rojas-Fernandez
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

Review 3.  Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor.

Authors:  Raf Van Campenhout; Serge Muyldermans; Mathieu Vinken; Nick Devoogdt; Timo W M De Groof
Journal:  Biomolecules       Date:  2021-01-06

4.  Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.

Authors:  Rahma Ben Abderrazek; Ayoub Ksouri; Faten Idoudi; Sayda Dhaouadi; Emna Hamdi; Cécile Vincke; Azer Farah; Zakaria Benlasfar; Hafedh Majdoub; Mohamed El Ayeb; Serge Muyldermans; Balkiss Bouhaouala-Zahar
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

5.  Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.

Authors:  Issam Hmila; Nishant N Vaikath; Nour K Majbour; Daniel Erskine; Indulekha P Sudhakaran; Vijay Gupta; Simona S Ghanem; Zeyaul Islam; Mohamed M Emara; Houari B Abdesselem; Prasanna R Kolatkar; Devaya K Achappa; Tatiana Vinardell; Omar M A El-Agnaf
Journal:  FEBS J       Date:  2022-02-25       Impact factor: 5.622

Review 6.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

Review 7.  A guide to: generation and design of nanobodies.

Authors:  Serge Muyldermans
Journal:  FEBS J       Date:  2020-08-28       Impact factor: 5.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.